Berger, Eloïse
Gelot, Amandine
Fournier, Agnès
Dossus, Laure
Boutron-Ruault, Marie-Christine
Severi, Gianluca
Castagné, Raphaële
Delpierre, Cyrille
Funding for this research was provided by:
French National Institute of Cancer (SHSESP 2017-130)
Article History
Received: 7 November 2023
Accepted: 14 March 2024
First Online: 14 April 2024
Declarations
:
: The authors declare no competing financial interests.
: The E3N study was approved by the French Commission for Data Protection and Privacy (NCT03285230, CNIL/<i>Commission national informatique et libertés</i>-no. 327346 V 13). All methods were carried out in accordance with relevant guidelines and regulations.
: All participants signed an informed consent form at study entry.
: Not applicable.